Low Hemoglobin: Why Anemia Happens and How to Raise It Back to Normal

Anemia — below-normal hemoglobin concentration — affects approximately 1.6 billion people globally according to WHO estimates. It is the most prevalent nutritional condition in the world, and its consequences (fatigue, reduced cognitive function, impaired exercise capacity, increased maternal and infant mortality in severe cases) are widely underappreciated because the condition is often sub-symptomatic until significant.

Treatment depends entirely on cause. Supplementing iron for B12-deficiency anemia does nothing; treating B12 deficiency with iron does nothing. The diagnostic work-up determines causation; treatment follows.

The Erythropoiesis Framework

Red blood cells (erythrocytes) are produced in the bone marrow from stem cells, under stimulation by erythropoietin (EPO, produced in the kidney in response to tissue hypoxia). A mature erythrocyte lives approximately 120 days, then is cleared by the spleen.

Anemia results from:

• 1. Reduced production: Insufficient raw materials (iron, B12, folate), insufficient EPO signal (kidney disease), bone marrow suppression (chemotherapy, aplastic anemia)
• 2. Increased destruction: Hemolysis (immune-mediated, mechanical, or hereditary causes)
• 3. Loss: Hemorrhage (acute or chronic occult blood loss)

Iron Deficiency Anemia (IDA)

The most common cause worldwide, accounting for approximately 50% of all anemia. Iron is required for hemoglobin synthesis — each hemoglobin molecule contains four iron atoms. Iron deficiency proceeds in stages:

• 1. Iron depletion: Ferritin falls below normal range, but hemoglobin is still maintained as iron is mobilized from stores
• 2. Iron-deficient erythropoiesis: Raw material shortage reduces hemoglobin production per erythrocyte
• 3. Iron deficiency anemia: Hemoglobin falls below the normal threshold (12 g/dL in women, 13 g/dL in men)

Laboratory signature: low hemoglobin + low MCV (microcytic, hypochromic erythrocytes) + low ferritin + low serum iron + high TIBC.

Treatment: Correct the cause of iron depletion and replete iron stores. Common causes include inadequate dietary iron and chronic blood loss (heavy menstruation, GI blood loss — testing for GI malignancy is indicated in post-menopausal women and men with IDA). Supplemental iron: ferrous sulfate 150–200 mg elemental iron per day in 2–3 divided doses; ferrous bisglycinate if GI intolerance.

> 📌 WHO recommends 120 mg elemental iron per day for 3 months to treat iron deficiency anemia; rebuilding ferritin stores typically requires 2–6 months of supplementation after hemoglobin normalizes. [1]

Vitamin B12 and Folate Deficiency

B12 and folate are both required for DNA synthesis in rapidly dividing cells, including erythrocyte precursors. Deficiency produces megaloblastic anemia: precursor cells cannot divide properly, yielding large (macrocytic, high MCV) erythrocytes that are functionally inferior.

Laboratory signature: high MCV + low B12 or folate + hypersegmented neutrophils on blood smear.

B12-specific features: B12 is obtained only from animal products (meat, fish, dairy, eggs). Strict vegetarians and vegans are at risk without supplementation. B12 absorption requires intrinsic factor (a gastric protein) — autoimmune destruction of intrinsic factor-producing parietal cells causes pernicious anemia, which requires intramuscular or high-dose oral B12.

Folate deficiency is typically dietary (low vegetable consumption) or demand-driven — which is why folate supplementation is standard in pregnancy.

---